Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s): LNDZF

Healthcare Medical Devices

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.

TSXV:EVMT - Post by User

Evome Medical Technologies Inc

Bullboard Posts

Comment by Volcom370on Sep 26, 2017 2:09pm

156 Views

Post# 26743598

RE:RE:Strategic Alternatives

Same here, I have been adding at 0.21 cent's. This play should work out well if you are patient enough.

constructionsite wrote: Excellent post, and I agree with your assessment and strategy. A 50% upside on this stock based on the current 0.21 trading price seems very very likely to materialize with even a marginally positive announcement. If by contrast we get the sale announcement that has been hinted at through recent releases, the upside could easily be 100% from here -- a double.

The fact is that this cf positive company is just a sleeping pile of cash waiting to be discovered by the market that has, for the time being, completely forgotten about it. IMO, this is lucky, since it allows buyers like me to keep making steady purchases. And while I agree with Rock that the halt could come any day now, I don't mind waiting a little longer if it allows me to use my regular income to keep purchasing more shares ;)

TheRock077 wrote:
Its been two months since the strategic iniative was announced.

At that time, they already had a recently received written indication of interest from an arm’s length party with respect to an acquisition of the Company’s business.

In addition, other Prospective purchasers had shown interest in purchasing the billing and collection division for cash on the basis that taking on the opportunity in a private setting would permit them the necessary time to give this business a chance at greater growth and success without the quarterly pressures of being a public company.

As a result of this , the Board has decided to pursue various strategic alternatives to enhance shareholder value, including the sale of some or all of the assets of Inspira, a merger or other business combination, the outright sale of Inspira, a spin out, or some combination thereof.
,

So, we must be now close to the most desirable option.

Hard book is 42 cents a share , mostly in cash and receivables.

The company is also cash flow positive.

These are metrics of compelling value, which is why I have been buying more.

At some point, we will be provided with an offer.

It wont be below 42 cents.

Brann bought nearly 5 millions at 37 cents.

I am ready for the halt..